MX2021008887A - Minociclina para el tratamiento del sindrome de pitt-hopkins. - Google Patents

Minociclina para el tratamiento del sindrome de pitt-hopkins.

Info

Publication number
MX2021008887A
MX2021008887A MX2021008887A MX2021008887A MX2021008887A MX 2021008887 A MX2021008887 A MX 2021008887A MX 2021008887 A MX2021008887 A MX 2021008887A MX 2021008887 A MX2021008887 A MX 2021008887A MX 2021008887 A MX2021008887 A MX 2021008887A
Authority
MX
Mexico
Prior art keywords
pitt
minocycline
treatment
hopkins syndrome
hopkins
Prior art date
Application number
MX2021008887A
Other languages
English (en)
Inventor
David Brown
Original Assignee
Healx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healx Ltd filed Critical Healx Ltd
Publication of MX2021008887A publication Critical patent/MX2021008887A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a la minociclina o a una sal farmacéuticamente aceptable de esta, para su uso en el tratamiento del síndrome de Pitt-Hopkins.
MX2021008887A 2019-02-26 2020-02-26 Minociclina para el tratamiento del sindrome de pitt-hopkins. MX2021008887A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1902580.8A GB201902580D0 (en) 2019-02-26 2019-02-26 Treatment
PCT/GB2020/050458 WO2020174237A1 (en) 2019-02-26 2020-02-26 Minocycline for the treatment of pitt-hopkins syndrome

Publications (1)

Publication Number Publication Date
MX2021008887A true MX2021008887A (es) 2021-08-19

Family

ID=65998986

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008887A MX2021008887A (es) 2019-02-26 2020-02-26 Minociclina para el tratamiento del sindrome de pitt-hopkins.

Country Status (12)

Country Link
US (1) US20220133752A1 (es)
EP (1) EP3930725A1 (es)
JP (1) JP2022521506A (es)
CN (1) CN113423406A (es)
AU (1) AU2020227913A1 (es)
BR (1) BR112021012859A2 (es)
CA (1) CA3125283A1 (es)
GB (1) GB201902580D0 (es)
IL (1) IL284747A (es)
MX (1) MX2021008887A (es)
WO (1) WO2020174237A1 (es)
ZA (1) ZA202104400B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092683A1 (en) * 2001-11-13 2003-05-15 Yansheng Du Use of tetracyclines as neuro-protective agents and for the treatment of parkinson's disease and related disorders
GB0703909D0 (en) * 2007-02-28 2007-04-11 Neuropharm Ltd Treatment of anxiety disorders
WO2009111064A2 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof

Also Published As

Publication number Publication date
CN113423406A (zh) 2021-09-21
IL284747A (en) 2021-08-31
BR112021012859A2 (pt) 2022-03-03
US20220133752A1 (en) 2022-05-05
EP3930725A1 (en) 2022-01-05
JP2022521506A (ja) 2022-04-08
AU2020227913A1 (en) 2021-07-08
ZA202104400B (en) 2022-07-27
WO2020174237A1 (en) 2020-09-03
GB201902580D0 (en) 2019-04-10
CA3125283A1 (en) 2020-09-03

Similar Documents

Publication Publication Date Title
PH12020500396A1 (en) Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
ZA202208783B (en) Kras mutant protein inhibitors
MX2019009443A (es) Metodos para tratar la influenza.
WO2018234568A3 (en) HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION
PH12019501970A1 (en) Pharmaceutical compositions for combination therapy
MX2018007704A (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
PH12016501750A1 (en) Human plasma kallikrein inhibitors
PH12018502742A1 (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
MX2020005484A (es) Formas solidas de un inhibidor de calicreina en plasma y sales del mismo.
PH12019501301A1 (en) Pharmaceutical compositions for combination therapy
MX2020008086A (es) Metodos y composiciones para tratar la apnea del sue?o.
MX2021014557A (es) Tratamientos de angioedema hereditario.
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
MX2021014558A (es) Tratamientos de angioedema.
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
CR20220216A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1
PH12021550883A1 (en) Crystalline salts of a plasma kallikrein inhibitor
TR201721505A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren kombi̇nasyon
ZA202105101B (en) Peptides for treatment and prevention of diabetes and associated disorders
MX2017013879A (es) Composiciones que comprenden anakinra.
MX2021003830A (es) Uso terapéutico del glucagón y combinación que incluye el mismo.
MX2021008887A (es) Minociclina para el tratamiento del sindrome de pitt-hopkins.
MX2019014784A (es) Tratamiento para la migra?a.
MX2021009663A (es) Tratamiento del sindrome de pitt-hopkins.